Quest Diagnostics 2014 Annual Report Download - page 88
Download and view the complete annual report
Please find page 88 of the 2014 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
(in millions unless otherwise indicated)
)
Pro Forma Combined Financial Information
7KHIROORZLQJXQDXGLWHGSURIRUPDFRPELQHGILQDQFLDOLQIRUPDWLRQUHIOHFWVWKHFRQVROLGDWHGVWDWHPHQWRIRSHUDWLRQVRI
WKH&RPSDQ\DVLIWKHDFTXLVLWLRQVRI6ROVWDVDQG6XPPLW+HDOWKKDGRFFXUUHGDVRI-DQXDU\7KHXQDXGLWHGSURIRUPD
LQIRUPDWLRQLQFOXGHVDGMXVWPHQWVSULPDULO\UHODWHGWRWKHDPRUWL]DWLRQRILQWDQJLEOHDVVHWVDFTXLUHGLQWHUHVWH[SHQVHDVVRFLDWHG
ZLWKGHEWH[WLQJXLVKHGSULRUWRWKHDFTXLVLWLRQVDQGWUDQVDFWLRQFRVWVUHODWHGWRWKH6ROVWDVDQG6XPPLW+HDOWKDFTXLVLWLRQV
7KHXQDXGLWHGSURIRUPDFRPELQHGILQDQFLDOLQIRUPDWLRQGRHVQRWLQFOXGHWKHHVWLPDWHGDQQXDOV\QHUJLHVH[SHFWHGWREH
UHDOL]HGXSRQFRPSOHWLRQRIWKHLQWHJUDWLRQRI6ROVWDVDQG6XPPLW+HDOWKDQGLVQRWLQGLFDWLYHRIWKHUHVXOWVRIRSHUDWLRQVDV
WKH\ZRXOGKDYHEHHQKDGWKHWUDQVDFWLRQEHHQHIIHFWHGRQWKHDVVXPHGGDWH3UHDFTXLVLWLRQILQDQFLDOLQIRUPDWLRQIRU$71
'LJQLW\&RQ9HUJHDQG6WHZDUGKDVQRWEHHQLQFOXGHGLQWKHWDEOHEHORZDVWKHVHDFTXLVLWLRQVZHUHQRWPDWHULDOWRWKH
&RPSDQ\¶VFRQVROLGDWHGILQDQFLDOVWDWHPHQWV
2014 2013
XQDXGLWHG
3URIRUPDQHWUHYHQXHV
3URIRUPDLQFRPHIURPFRQWLQXLQJRSHUDWLRQV
Earnings per share attributable to Quest Diagnostics’ common stockholders - basic:
3URIRUPDLQFRPHIURPFRQWLQXLQJRSHUDWLRQV
Earnings per share attributable to Quest Diagnostics’ common stockholders - diluted:
3URIRUPDLQFRPHIURPFRQWLQXLQJRSHUDWLRQV
6. DISPOSITIONS
Sale of Royalty Rights
$VSDUWRILWVDFTXLVLWLRQRI&HOHUDLQWKH&RPSDQ\JDLQHGULJKWVWRUHFHLYHUR\DOWLHVRQLEUXWLQLEDQ
H[SHULPHQWDOFDQFHUWKHUDS\,Q-XO\WKH&RPSDQ\VROGLWVULJKWWRUHFHLYHUR\DOWLHVUHODWHGWRWKHFRPPHUFLDOL]DWLRQRI
LEUXWLQLEIRUPLOOLRQLQFDVK7KH&RPSDQ\KDVDFFRXQWHGIRUWKLVWUDQVDFWLRQDVDVDOHRIUR\DOW\ULJKWVDQGUHFRJQL]HGD
SUHWD[JDLQRIPLOOLRQQHWRIWUDQVDFWLRQFRVWVDVVRFLDWHGZLWKWKLVVDOH
Sale of Enterix
,Q6HSWHPEHUWKH&RPSDQ\FRPSOHWHGWKHVDOHRI(QWHUL[DQGUHFRUGHGDSUHWD[ORVVRIDSSUR[LPDWHO\
PLOOLRQDVVRFLDWHGZLWKWKHVDOHZKLFKLVLQFOXGHGLQRWKHURSHUDWLQJLQFRPHH[SHQVHQHW7KH(QWHUL[EXVLQHVVZDVQRW
UHFODVVLILHGWRGLVFRQWLQXHGRSHUDWLRQVGXHWRWKHOHYHORIFRQWLQXLQJLQYROYHPHQWLQWKH(QWHUL[EXVLQHVVVXEVHTXHQWWRLWVVDOH
7KHFRQWLQXLQJLQYROYHPHQWUHODWHVWRDPLQLPXPSXUFKDVHDJUHHPHQWEHWZHHQWKHDFTXLURURIWKH(QWHUL[EXVLQHVVDQGWKH
&RPSDQ\
Sale of HemoCue
,Q$SULOWKH&RPSDQ\FRPSOHWHGWKHVDOHRI+HPR&XHDQGUHFRUGHGDQDIWHUWD[JDLQRIPLOOLRQLQFOXGLQJ
IRUHLJQFXUUHQF\WUDQVODWLRQDGMXVWPHQWVSDUWLDOO\RIIVHWE\LQFRPHWD[H[SHQVHDQGWUDQVDFWLRQFRVWVZKLFKLVLQFOXGHGLQ
GLVFRQWLQXHGRSHUDWLRQVLQ)RUIXUWKHUGHWDLOVUHJDUGLQJWKHVDOHRI+HPR&XHVHH1RWH
Sale of OralDNA
7KH&RPSDQ\FRPSOHWHGWKHVDOHRI2UDO'1$LQ'HFHPEHU)RUIXUWKHUGHWDLOVUHJDUGLQJWKHVDOHRI2UDO'1$
VHH1RWH
48(67',$*1267,&6)250
.